세계의 인간성장호르몬 시장 보고서(2025년)

Human growth hormone (HGH) is a peptide hormone originating from the pituitary gland, playing a vital role in encouraging growth, cell replication, and tissue renewal across the human body. It finds application in medical interventions targeting growth hormone deficiency, promoting muscle growth, and addressing age-related issues such as muscle atrophy and decreased bone density.

The primary forms of human growth hormone are liquid and powder. Liquid human growth hormone products are typically presented as a solution or suspension, readily available for immediate consumption or injection. These include various brands such as Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, among others, administered via different routes such as oral, intravenous, intramuscular, or subcutaneous. These products are distributed through diverse channels such as hospital pharmacies, retail pharmacies, online pharmacies, and specialty pharmacies, catering to a range of applications such as growth hormone (GH) deficiency, adult GH deficiency, pediatric GH deficiency, Turner syndrome, idiopathic short stature, Prader-Willi syndrome, small for gestational age, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The human growth hormone market research report is one of a series of new reports from The Business Research Company that provides human Growth hormone market statistics, including human growth hormone industry global market size, regional shares, competitors with a human growth hormone market share, detailed human growth hormone market segments, market trends, and opportunities, and any further data you may need to thrive in the human growth hormone industry. This human growth hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human growth hormone market size has grown strongly in recent years. It will grow from $4.75 billion in 2024 to $5.18 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing prevalence of growth disorders, rising awareness about hormone therapies, expanding applications in sports medicine, growing geriatric population, improving healthcare infrastructure.

The human growth hormone market size is expected to see strong growth in the next few years. It will grow to $7.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to emergence of personalized medicine, rising healthcare expenditure globally, increasing adoption of recombinant DNA technology, growing demand for hormone replacement therapies, rising prevalence of endocrine disorders. Major trends in the forecast period include expansion of distribution networks in emerging markets, integration of artificial intelligence in drug development, emphasis on sustainable manufacturing processes, development of long-acting formulations, utilization of combination therapies for enhanced efficacy.

The forecast of 9.0% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. medical supply chains by increasing costs for recombinant Human Growth Hormone injections imported from Belgium and France, potentially leading to higher pediatric endocrinology expenses and delayed growth disorder treatments. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing awareness of treatment procedures is anticipated to drive the expansion of the human growth hormone market in the future. Treatment procedures encompass medical interventions aimed at alleviating, managing, or curing health conditions or diseases. This heightened awareness is fueled by advancements in medical technology, enhanced access to information via digital media, and a growing public interest in health and wellness. Human growth hormone (HGH) treatments have attracted significant media attention and public interest, underscoring the benefits and potential applications of modern medical interventions, thereby boosting overall awareness of treatment procedures. For example, according to the 2022 National Survey on Drug Use and Health (NSDUH) report by the Substance Abuse and Mental Health Services Administration (SAMHSA), among adolescents aged 12 to 17, in 2021, 40.6% of the 5.0 million adolescents with a past year Major Depressive Episode (MDE) received treatment for depression, while in 2022, 56.8% of the 4.8 million adolescents with a past year MDE received mental health treatment. Consequently, the heightened awareness of treatment procedures is propelling the growth of the human growth hormone market.

Leading companies in the human growth hormone market are intensifying their efforts in drug development and approvals to enhance their medication offerings and provide superior treatment solutions. Drug development entails a comprehensive and meticulous process involving multiple stages to ensure the safety, efficacy, and quality of a new drug before it is introduced to the market. For example, in June 2023, Pfizer Inc., a US-based biopharmaceutical company, and OPKO Health Inc., a US-based biopharmaceutical and diagnostics company, announced the approval of NGENLA (somatrogon-ghla) by the Food and Drug Administration (FDA). This treatment offers a more convenient dosing regimen and enhances patient adherence compared to daily injections. It provides children with growth hormone deficiency the option to reduce injection frequency from daily to once a week. The FDA approval was supported by a Phase 3 study demonstrating NGENLA's non-inferiority to once-daily somatropin, with a safety profile comparable to somatropin.

The increasing healthcare expenditure is expected to drive the growth of the human growth hormone (HGH) market in the coming years. Healthcare expenditure refers to the total spending on health services, products, and interventions aimed at improving and maintaining health. HGH therapy provides a unique approach to reducing healthcare costs by addressing underlying health issues that contribute to long-term expenses, enhancing recovery and quality of life, and potentially preventing the onset of expensive chronic conditions. For instance, in May 2023, a report from the Office for National Statistics, a UK-based government agency, indicated that healthcare spending in the UK grew by 5.6% between 2022 and 2023, compared to just 0.9% in 2022. The total healthcare expenditure in the UK was approximately $317.63 billion (£292 billion) in 2023. As a result, the rise in healthcare spending is expected to drive the human growth hormone market forward.

Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., Shanghai United Imaging Healthcare Co. Ltd., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human growth hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The human growth hormone market consists of sales of combination therapies, sustained-release formulations, long-acting formulations, biosimilar versions, pediatric-specific formulations, and personalized dosing regimens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Growth Hormone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human growth hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human growth hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The human growth hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Liquid; Powder
• 2) By Brand: Norditropin; Genotropin; Humatrope; Saizen; Omnitrope; Skytrofa; Others Brands
• 3) By Route Of Administration: Oral; Intravenous; Intramuscular; Subcutaneous
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacy; Specialty Pharmacy
• 5) By Application: Growth Hormone (GH) Deficiency; Adult Growth Hormone (GH) Deficiency; Pediatric Growth Hormone (GH) Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader-Willi Syndrome; Small For Gestational Age; Other Applications
• Subsegments:
• 1) By Liquid: Pre-Filled Liquid Syringes; Vials Of Liquid Growth Hormone
• 2) By Powder: Reconstitutable Powder; Freeze-Dried Powder
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; Novartis AG; Thermo Fisher Scientific Inc.; Eli Lilly and Company; Novo Nordisk A/S; Merck KGaA; Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; Ipsen Pharma; Ferring Holding SA; Endo International; Zydus Lifesciences Limited; Opko Health; LG Life Sciences; EMD Serono Inc.; Wockhardt Ltd.; JCR Pharmaceuticals Co. Ltd.; Genentech Inc.; Shanghai United Imaging Healthcare Co. Ltd.; SOFAR S.p.A.; United Laboratories; Ascendis Pharma; Uni-Pharma S.A.; Versartis Inc.; Reliance Life Sciences; Anhui Anke Biotechnology (Group) Co. Ltd.; Rani Therapeutics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Growth Hormone Market Characteristics

3. Human Growth Hormone Market Trends And Strategies

4. Human Growth Hormone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Human Growth Hormone Growth Analysis And Strategic Analysis Framework

• 5.1. Global Human Growth Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Human Growth Hormone Market Growth Rate Analysis
• 5.4. Global Human Growth Hormone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Human Growth Hormone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Human Growth Hormone Total Addressable Market (TAM)

6. Human Growth Hormone Market Segmentation

• 6.1. Global Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid
• Powder
• 6.2. Global Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Norditropin
• Genotropin
• Humatrope
• Saizen
• Omnitrope
• Skytrofa
• Others Brands
• 6.3. Global Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Intramuscular
• Subcutaneous
• 6.4. Global Human Growth Hormone Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacy
• Specialty Pharmacy
• 6.5. Global Human Growth Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Growth Hormone (GH) Deficiency
• Adult Growth Hormone (GH) Deficiency
• Pediatric Growth Hormone (GH) Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small For Gestational Age
• Other Applications
• 6.6. Global Human Growth Hormone Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Filled Liquid Syringes
• Vials Of Liquid Growth Hormone
• 6.7. Global Human Growth Hormone Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reconstitutable Powder
• Freeze-Dried Powder

7. Human Growth Hormone Market Regional And Country Analysis

• 7.1. Global Human Growth Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Human Growth Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Growth Hormone Market

• 8.1. Asia-Pacific Human Growth Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Growth Hormone Market

• 9.1. China Human Growth Hormone Market Overview
• 9.2. China Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Growth Hormone Market

• 10.1. India Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Growth Hormone Market

• 11.1. Japan Human Growth Hormone Market Overview
• 11.2. Japan Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Growth Hormone Market

• 12.1. Australia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Growth Hormone Market

• 13.1. Indonesia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Growth Hormone Market

• 14.1. South Korea Human Growth Hormone Market Overview
• 14.2. South Korea Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Growth Hormone Market

• 15.1. Western Europe Human Growth Hormone Market Overview
• 15.2. Western Europe Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Growth Hormone Market

• 16.1. UK Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Growth Hormone Market

• 17.1. Germany Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Growth Hormone Market

• 18.1. France Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Growth Hormone Market

• 19.1. Italy Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Growth Hormone Market

• 20.1. Spain Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Growth Hormone Market

• 21.1. Eastern Europe Human Growth Hormone Market Overview
• 21.2. Eastern Europe Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Growth Hormone Market

• 22.1. Russia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Growth Hormone Market

• 23.1. North America Human Growth Hormone Market Overview
• 23.2. North America Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Growth Hormone Market

• 24.1. USA Human Growth Hormone Market Overview
• 24.2. USA Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Growth Hormone Market

• 25.1. Canada Human Growth Hormone Market Overview
• 25.2. Canada Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Growth Hormone Market

• 26.1. South America Human Growth Hormone Market Overview
• 26.2. South America Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Growth Hormone Market

• 27.1. Brazil Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Growth Hormone Market

• 28.1. Middle East Human Growth Hormone Market Overview
• 28.2. Middle East Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Growth Hormone Market

• 29.1. Africa Human Growth Hormone Market Overview
• 29.2. Africa Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Growth Hormone Market Competitive Landscape And Company Profiles

• 30.1. Human Growth Hormone Market Competitive Landscape
• 30.2. Human Growth Hormone Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Human Growth Hormone Market Other Major And Innovative Companies

• 31.1. Novo Nordisk A/S
• 31.2. Merck KGaA
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Sandoz International GmbH
• 31.5. Ipsen Pharma
• 31.6. Ferring Holding SA
• 31.7. Endo International
• 31.8. Zydus Lifesciences Limited
• 31.9. Opko Health
• 31.10. LG Life Sciences
• 31.11. EMD Serono Inc.
• 31.12. Wockhardt Ltd.
• 31.13. JCR Pharmaceuticals Co. Ltd.
• 31.14. Genentech Inc.
• 31.15. Shanghai United Imaging Healthcare Co. Ltd.

32. Global Human Growth Hormone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Growth Hormone Market

34. Recent Developments In The Human Growth Hormone Market

35. Human Growth Hormone Market High Potential Countries, Segments and Strategies

• 35.1 Human Growth Hormone Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Human Growth Hormone Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Human Growth Hormone Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer